sur Siegfried AG (isin : CH0014284498)
Siegfried AG Unveils EVOLVE+ Strategy for Sustained Growth
Siegfried AG, a prominent global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical sector, announced its updated strategy, EVOLVE+, during its Capital Markets Day in Barberà del Vallès, Spain. Led by CEO Marcel Imwinkelried, the strategy aims to enhance Siegfried’s position as a key provider in the pharma industry, building on the successful EVOLVE foundation.
Key initiatives under EVOLVE+ include expanding core business operations, integrating new technology and services, and narrowing focus on commercial and operational excellence. This approach targets robust growth with continued value-added mergers and acquisitions. Financial goals remain steady, with an outlook for market-leading growth and increased profitability.
EVOLVE+ underscores Siegfried's commitment to being an employer of choice within the industry while delivering shareholder value.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Siegfried AG